Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Polymyalgia Rheumatica

Staff  |  Issue: April 2008  |  April 1, 2008

Polymyalgia rheumatica (PMR) is a relatively common cause of widespread aching and stiffness in older adults. PMR can overlap with another rheumatic disease called giant cell arteritis, and symptoms of the two conditions can occur at the same time or separately. (See p. 12 of the March 2008 issue for more on giant cell arteritis.) The typical symptoms of PMR include aching and stiffness around the upper arms, neck, lower back, buttocks, and thighs. Symptoms tend to develop quickly over a period of several days or weeks, and occasionally even overnight.

PMR occurs only in older adults. The average age of symptom onset is 70, and many people who have PMR are 80 or older. Women are affected somewhat more often than men. The disease is more frequent in whites than other races, but all races are susceptible. PMR is not unusual—in fact, it is diagnosed for the first time in older adults more frequently than RA.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The cause of PMR is unknown. The tendency for symptoms to begin abruptly suggests the possibility of an infection but, so far, no specific infection has been found. According to patient–fact sheet writer William Docken, MD, “recent evidence now suggests that PMR is an arthritis with a particular tendency to involve the shoulder and hip joints, and the bursae (or sacs) around these joints. Thus, the pain in the upper arms and thighs comes from the nearby shoulder and hip joints.” Symptoms of PMR are usually worse at night and when first rising in the morning.

Rheumatologists use blood tests to diagnose PMR. The blood tests may show abnormally increased inflammation, but in a small proportion of patients, these tests may be normal or only slightly increased. If PMR is strongly suspected, a trial of low-dose corticosteroids is given, usually in the form of 10–15 mg of prednisone per day.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

If PMR is present, these medications will control the pain quickly. The response to corticosteroids can be dramatic; some patients are better after only one dose and (once stiffness has subsided) normal activities can be resumed, including exercise as tolerated. However, if symptoms have not been completely relieved after two to three weeks of treatment, other diagnoses should be considered.

Download the complete PMR fact sheet and other patient education materials at www.rheumatology.org by following the links to patient education from the Practice Support menu.

Share: 

Filed under:ConditionsFrom the CollegeSoft Tissue Pain Tagged with:patient educationPatient Fact SheetPolymyalgia Rheumatica

Related Articles

    Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

    March 1, 2013

    Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

    Polymyalgia Rheumatica: New Tricks for an Old Disease

    January 29, 2024

    Originally posted Feb. 13, 2023; reposted in conjunction with publication of the PMR supplement to the February 2024 issue of The Rheumatologist. PHILADELPHIA—Polymyalgia rheumatica (PMR) is a chronic inflammatory condition that almost exclusively affects individuals older than 50.1 First described in 1888, PMR has been a recognized rheumatic disease since at least 1957. Diagnosing the…

    Permanent Vision Loss in Late Giant Cell Arteritis

    October 18, 2018

    Patients with polymyalgia rheumatica (PMR) or peripheral arthritis may require extra vigilance during treatment because of a suspected link to giant cell arteritis (GCA) and, potentially, permanent vision loss. “Development of giant cell arteritis after treating polymyalgia or peripheral arthritis: a retrospective case-control study,” a March 2018 study published in The Journal of Rheumatology, suggests…

    How to Manage Polymyalgia Rheumatica

    December 16, 2015

    Recognizing the need to provide guidance on the current disparate management of polymyalgia rheumatica (PMR), the American College of Rheumatology (ACR), in collaboration with the European League Against Rheumatism (EULAR), recently published the first international set of recommendations for the screening, treatment and management of PMR.1,2 Specifically, the recommendations offer guidance on the use of…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences